Lisa Caperelli | Vice President of Investor Relations |
Bill Collier | President and Chief Executive Officer |
David Hastings | Chief Financial Officer |
Gaston Picchio | Chief Development Officer |
Mike Sofia | Chief Scientific Officer |
Dennis Ding | Jefferies |
Roy Buchanan | JMP |
Keay Nakae | Chardan |
Good day. And thank you for standing by, and welcome to Arbutus Biopharma Corporation's 2022 Third Quarter Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.